BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34870814)

  • 1. Measuring Mutator Enzyme Activity Using an E. coli-Based Colony Formation Assay.
    Liu MC; Fugmann SD
    Methods Mol Biol; 2022; 2421():103-114. PubMed ID: 34870814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA-editing cytidine deaminase Apobec-1 is unable to induce somatic hypermutation in mammalian cells.
    Eto T; Kinoshita K; Yoshikawa K; Muramatsu M; Honjo T
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12895-8. PubMed ID: 14559972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high-throughput assay for DNA deaminases.
    Wang M; Rada C; Neuberger MS
    Methods Mol Biol; 2011; 718():171-84. PubMed ID: 21370049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cytidine deaminases AID and APOBEC-1 exhibit distinct functional properties in a novel yeast selectable system.
    Krause K; Marcu KB; Greeve J
    Mol Immunol; 2006 Feb; 43(4):295-307. PubMed ID: 15963568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse APOBEC1 cytidine deaminase can induce somatic mutations in chromosomal DNA.
    Caval V; Jiao W; Berry N; Khalfi P; Pitré E; Thiers V; Vartanian JP; Wain-Hobson S; Suspène R
    BMC Genomics; 2019 Nov; 20(1):858. PubMed ID: 31726973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo.
    Beale RC; Petersen-Mahrt SK; Watt IN; Harris RS; Rada C; Neuberger MS
    J Mol Biol; 2004 Mar; 337(3):585-96. PubMed ID: 15019779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cytidine deaminase AID exhibits similar functional properties in yeast and mammals.
    Rogozin IB; Pavlov YI
    Mol Immunol; 2006 Mar; 43(9):1481-4. PubMed ID: 16219354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation-induced cytidine deaminase fails to induce a mutator phenotype in the human pre-B cell line Nalm-6.
    Rückerl F; Bachl J
    Eur J Immunol; 2005 Jan; 35(1):290-8. PubMed ID: 15593119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review).
    He X; Li J; Wu J; Zhang M; Gao P
    Mol Med Rep; 2015 Nov; 12(5):6405-14. PubMed ID: 26398702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic hypermutation in immunity and cancer: Critical analysis of strand-biased and codon-context mutation signatures.
    Steele EJ
    DNA Repair (Amst); 2016 Sep; 45():1-24. PubMed ID: 27449479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expansions, diversification, and interindividual copy number variations of AID/APOBEC family cytidine deaminase genes in lampreys.
    Holland SJ; Berghuis LM; King JJ; Iyer LM; Sikora K; Fifield H; Peter S; Quinlan EM; Sugahara F; Shingate P; Trancoso I; Iwanami N; Temereva E; Strohmeier C; Kuratani S; Venkatesh B; Evanno G; Aravind L; Schorpp M; Larijani M; Boehm T
    Proc Natl Acad Sci U S A; 2018 Apr; 115(14):E3211-E3220. PubMed ID: 29555777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOBEC and ADAR deaminases may cause many single nucleotide polymorphisms curated in the OMIM database.
    Lindley RA; Hall NE
    Mutat Res; 2018 Jul; 810():33-38. PubMed ID: 29957488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vertebrate immunity: mutator proteins and their evolution].
    Lada AG; Iyer LM; Rogozin IB; Aravind L; Pavlov IuI
    Genetika; 2007 Oct; 43(10):1311-27. PubMed ID: 18069336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases.
    Conticello SG; Thomas CJ; Petersen-Mahrt SK; Neuberger MS
    Mol Biol Evol; 2005 Feb; 22(2):367-77. PubMed ID: 15496550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators.
    Harris RS; Petersen-Mahrt SK; Neuberger MS
    Mol Cell; 2002 Nov; 10(5):1247-53. PubMed ID: 12453430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity.
    MacGinnitie AJ; Anant S; Davidson NO
    J Biol Chem; 1995 Jun; 270(24):14768-75. PubMed ID: 7782343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenesis by AID, a molecule critical to immunoglobulin hypermutation, is not caused by an alteration of the precursor nucleotide pool.
    Diaz M; Ray M; Wheeler LJ; Verkoczy LK; Mathews CK
    Mol Immunol; 2003 Sep; 40(5):261-8. PubMed ID: 12943798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A portable hot spot recognition loop transfers sequence preferences from APOBEC family members to activation-induced cytidine deaminase.
    Kohli RM; Abrams SR; Gajula KS; Maul RW; Gearhart PJ; Stivers JT
    J Biol Chem; 2009 Aug; 284(34):22898-904. PubMed ID: 19561087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of cytidine deaminases.
    Navaratnam N; Sarwar R
    Int J Hematol; 2006 Apr; 83(3):195-200. PubMed ID: 16720547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification.
    Petersen-Mahrt SK; Harris RS; Neuberger MS
    Nature; 2002 Jul; 418(6893):99-103. PubMed ID: 12097915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.